Carolyn E. Taylor - 09 May 2022 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Director
Signature
/s/ Jessica Morris as attorney-in-fact
Issuer symbol
TNXP
Transactions as of
09 May 2022
Transactions value $
$0
Form type
4
Filing time
11 May 2022, 17:49:47 UTC
Previous filing
27 Jul 2021
Next filing
10 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNXP Stock Option Award $0 +2,131,500 $0 2,131,500 09 May 2022 Common Stock 2,131,500 $0.132 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.